Pan, D., Du, L., Liu, J., Kuerban, K., Huang, X., Wang, Y., . . . Ye, L. In Situ Vaccination with a Vpr-Derived Peptide Elicits Systemic Antitumor Immunity by Improving Tumor Immunogenicity. MDPI AG.
Chicago Style (17th ed.) CitationPan, Danjie, et al. In Situ Vaccination with a Vpr-Derived Peptide Elicits Systemic Antitumor Immunity by Improving Tumor Immunogenicity. MDPI AG.
MLA (9th ed.) CitationPan, Danjie, et al. In Situ Vaccination with a Vpr-Derived Peptide Elicits Systemic Antitumor Immunity by Improving Tumor Immunogenicity. MDPI AG.
Warning: These citations may not always be 100% accurate.